News

Filter

Current filters:

bosentan

1 to 9 of 156 results

Soaring Tracleer sales boost Actelion’s 2009 financial results

19-02-2010

Switzerland-based Actelion, Europe’s largest biotechnology company, pleased investors yesterday…

BiotechnologybosentanDrug DiscoveryFinancialGlaxoSmithKlineGSKIloprostMiglustatPharmaceuticalTracleerVentavisZavesca

Actelion’s Tracleer gets US label extension

10-08-2009

Swiss biotechnology firm Actelion says that the US Food and Drug Administration has approved the company‘s…

BiotechBiotechnologybosentanCardio-vascularEuropeNystatinOralTracleer

Tracleer plus tadalafil boosts 6MWD

28-05-2009

Patients with pulmonary arterial hypertension who received an additional 20mg or 40mg dose of Eli Lilly's…

bosentanCialisLillyNystatinOralTadalafilTracleer

IDSMB gives go ahead for Actelion IPS trial

11-05-2009

Swiss firm Actelion says that the Independent Data and Safety Monitoring Board has recommended the continuation…

bosentanTracleer

Actelion's 1st-qtr profit doubles on forex effect

27-04-2009

Shares in Actelion leapt 8% to 3.83 Swiss francs on April 22, after the Swiss biotechnology firm said…

bosentanTracleer

FDA asks for REMS before expanding Tracleer use

09-03-2009

The US Food and Drug Administration has asked Swiss drugmaker Actelion for a risk evaluation and mitigation…

bosentanTracleer

1 to 9 of 156 results

COMPANY SPOTLIGHT

Menarini

Back to top